Penn Center for Myeloproliferative Neoplasms

Penn Bone Marrow and Stem Cell Transplant Center

Penn Bone Marrow and Stem Cell Transplant Program, approved and funded by the National Cancer Institute, is one of the largest and most experienced transplant programs in the country.  Penn Bone Marrow Transplant Program has pioneered many advances in the care of bone marrow transplant patients, including the use of autologous stem cell grafts, transplantation using unrelated and mismatched sibling donors, and developing less toxic non-myeloablative preparatory regiments that improve outcomes and decrease toxicity. Penn transplant team has decades of transplantation experience including expertise in transplantation of patients with myelofibrosis and other high risk myeloproliferative disorders. The transplant care is closely coordinated between our dedicated inpatient transplant unit and the outpatient clinic, with a clinical team of experienced transplant physicians, nurses, nutritionists, physical therapists and social workers who understand the multitude of personal issues faced during transplant.

Transplant Team:

Learn more about Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation at the National Cancer Institute.

The Penn Difference

  • Individualized Treatment Plan
  • Expert Treatment Team Knowledgeable in Myeloproliferative Disorders
  • State-of-the-Art Personalized Diagnostic Testing
  • Access to Newest Therapies Through Clinical Trials
  • Comprehensive Bone Marrow Transplantation Service
  • Integrated Care by a Multidisciplinary Treatment Team

Make an Appointment

New Patients:
Abramson Cancer Center
Perelman Center for Advanced Medicine
2nd Floor, West Pavilion
Philadelphia, PA 19104
Phone: 215-615-5858 option 2
Fax: 215-615-5889

Current Patients:
Contact your doctor directly

For General Inquiries:
Call the Myeloproliferative Neoplasms Program at  215-614-1847